Optimizing Care Closer to Home
“We believe high-quality speciality testing, like treatment, should be close to where a patient resides.”
– Dr. Gang Song, Founder
Chief Executive Officer
Mr. Randy Pritchard is CEO of Pillar Biosciences. He has more than 24 years of healthcare experience as a diagnostics executive who has deep experience in corporate and commercial strategy, sales and marketing, and driving growth through innovation. He has held positions of increasing responsibilities, including SVP of US Diagnostics marketing, SVP & Lifecycle Leader at the divisions of POC Diagnostic & Core Reagents, and VP of Marketing at Centralized Diagnostics at Roche Diagnostics. He completed his undergraduate studies at Purdue University and his MBA at Indiana Wesleyan University.
Zhaohui Wang, Ph.D.
Co-founder and Chief Scientific Officer
Dr. Zhaohui Wang co-founded Pillar Biosciences, and co-invented SLIMamp technology. Previously, she held positions of increasing responsibility at LabCorp (previously Genzyme Genetics) and IQuum (subsequently acquired by Roche Molecular Diagnostics). Dr. Wang received her Ph.D. in Cellular and Molecular Biology from the University of Massachusetts, Amherst.
Chief Financial Officer
Mr. Vincent Ricci is the CFO of Pillar Biosciences. He has two decades of experience as an investment professional focusing on the global healthcare and life sciences industry. He joins Pillar Biosciences from Davidson Kempner Capital Management LP, where he was responsible for equity investments in the life sciences sector. Previously, Mr. Ricci was a Portfolio Manager for Alliance Bernstein where he managed investments across the global healthcare industry. Mr. Ricci began his career at Wachovia Bank N.A. in their Capital Markets division where he was a Vice President and Senior Equity Analyst covering the small and mid-cap medical device industry. Mr. Ricci received his Master of Medical Science from Drexel University College of Medicine and his Bachelor of Arts in Economics and Biology from the University of Pennsylvania.
Chief Commercial Officer
Mr. Dan Harma is the Chief Commercial Officer of Pillar Biosciences. He has more than 30 years of experience in the medical device industry, notably in in-vitro diagnostics, molecular diagnostics, and hematology markets. Prior to joining Pillar Biosciences, he served as Chief Commercial Officer at NeuMoDxTM where he led the commercial team and assisted in transitioning the business from research and development stage to full commercialization. Previously, he held multiple roles at Abbott Laboratories, Inc., in both the Diagnostics and Molecular divisions. His positions included oversight of product marketing, sales leadership, and commercial development. Mr. Harma received his MBA from Loyola University and his BBA in Marketing from the University of Wisconsin-Whitewater.
Vice President of Operations
Mr. Mike Crowell is VP of Operations for Pillar Biosciences. He has more than 25 years of healthcare experience with 20 plus years leading operations for molecular diagnostic companies. He has developed deep experience helping regulated life sciences organizations achieve sustained competitive advantage and growth through enhanced customer experience, operational efficiency, organizational agility, and continuous process improvement. He has held positions of increasing responsibilities, including Sr. Director of Operations, Supply Chain and OpEx with Illumina Inc., and Sr. Director Global Supply Chain with Tethys Bioscience and Monogram Biosciences (LabCorp) respectively. Mr. Crowell received a master’s degree from National University of Singapore in International Business as well as an MBA from UCLA Anderson School of Management.
Ms. Christa Adkins is General Counsel at Pillar Biosciences. She has more than 20 years of experience as internal counsel to multi-national corporations and early-stage companies. Prior to joining Pillar Biosciences, she served as General Counsel, Corporate Secretary, and Member of the Equity Incentive Plan Committee at Vibenomics, Inc. Previously, she spent more than 10 years at Roche Diagnostic Corporation, as Commercial Lawyer and Director of Ethics and Compliance. She also has extensive nonprofit board leadership experience and is currently the Chair of the Board of Trustees for the Nature Conservancy of Indiana, Trustee for the Indianapolis Zoological Society, and Trustee for the Orchard School. Ms. Adkins holds a JD from Indiana University Robert H. McKinney School of Law and a BS in Economics from Purdue University.
Board of Directors
Gang Song – Chairman of the Board
Randy Pritchard – Director
Robert Forrester – Director
Co-Founder of IDRx and EQRx
Simone Song – Director
Founder and Senior Partner, ORI Capital
Dr. Guoqiang Wang – Director
General Manager, Jiangsu Bioperfectus Technologies Co., Ltd.
Isaac Ro – Observer
Partner, Catalio Capital
Shawn Liu – Director
Chairman of the Board, China Biotech Services Holdings Limited
Eric Lai, Ph.D. – Director
Former SVP of Genomic Medicine, Takeda
Scientific Advisory Board
Siraj Ali, MD, Ph.D.
VP of Clinical Development, EQRx Inc.
Cheng-Zhong Zhang, Ph.D.
Co-Founder, Pillar. Professor, Harvard Medical Shool
Marcia Eisenberg, Ph.D.
Chief Scientific Officer, Sr. VP, LabCorp
Timothy Springer, Ph.D.
Professor, Harvard Medical School
Paul M. Waring, MBBS, Ph.D., FRCPA, FRCPath, FHGSA, FFSc(RCPA)
Executive Director, Translational Pathology, AstraZenica
Pillar Biosciences Inc.
9 Strathmore Rd., Natick MA, 01760